Literature DB >> 7958686

The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data.

B L Weusten1, J M Roelofs, L M Akkermans, G P Van Berge-Henegouwen, A J Smout.   

Abstract

BACKGROUND/AIMS: All methods currently used to quantify the temporal relationships between symptoms and episodes of gastroesophageal reflux, as assessed by 24-hour pH monitoring, have major shortcomings. The aim of this study was to develop and validate a simple, all-comprising statistical method to calculate the probability that gastroesophageal reflux episodes and symptoms are associated.
METHODS: The 24-hour pH signal was divided into consecutive 2-minute periods. These periods and the 2-minute periods preceding the onset of symptoms were evaluated for the occurrence of reflux. Fisher's Exact Test was then applied to calculate the probability (P value) that reflux and symptom episodes were unrelated. Finally, the symptom-association probability (SAP) was calculated as (1.0 - P) x 100%. The SAP values found in 184 24-hour esophageal pH tests were compared with the symptom index and the symptom sensitivity index.
RESULTS: Discordance between the SAP and the symptom index was found in 21 patients (11%) and discordance between the SAP and the symptom-sensitivity index in 28 (15%). False-positive and false-negative symptom index values occurred preferentially in patients with small and large numbers of symptom episodes during the test, respectively (P < 0.05).
CONCLUSIONS: The SAP is a single, simple, quantitative measure of the strength of the association between symptoms and reflux episodes that is devoid of the disadvantages inherent to previously used methods.

Entities:  

Mesh:

Year:  1994        PMID: 7958686     DOI: 10.1016/0016-5085(94)90815-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  120 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Most GERD symptoms are not due to acid reflux in patients with very low 24-hour acid contact times.

Authors:  Bryan T Green; J Barry O'Connor
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

3.  Use of symptom indices in the management of GERD.

Authors:  Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

Review 4.  Management of the patient with incomplete response to PPI therapy.

Authors:  Peter J Kahrilas; Guy Boeckxstaens; Andre J P M Smout
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-06       Impact factor: 3.043

5.  Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.

Authors:  Amit Patel; Gregory S Sayuk; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-23       Impact factor: 11.382

6.  GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.

Authors:  A Patel; G S Sayuk; V M Kushnir; W W Chan; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2015-12-20       Impact factor: 3.598

7.  Value of preoperative esophageal function studies before laparoscopic antireflux surgery.

Authors:  Walter W Chan; Laura R Haroian; C Prakash Gyawali
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

8.  Capsule pH monitoring: is wireless more?

Authors:  R H Holloway
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

9.  Hypopharyngeal multichannel intraluminal impedance leads to the promising outcome of antireflux surgery in Japanese population with laryngopharyngeal reflux symptoms.

Authors:  Takeshi Suzuki; Yosuke Seki; Yoshitaka Okamoto; Toshitaka Hoppo
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

10.  Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring.

Authors:  D Sifrim; L Dupont; K Blondeau; X Zhang; J Tack; J Janssens
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.